Abstract: Healthcare-associated infections (HAIs) may be diverse among patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). However studies were limited. We aimed to quantify and compare the characteristics and relevant factors associated with HAIs among patients with AML and ALL. The surveillance-based study was conducted in a university teaching hospital. All adult patients diagnosed with acute leukemia (AL) and admitted into the Hematology Department for over 48 h were included. HAI characteristics and relevant factors were compared between AML and ALL patients. A consecutive sample of 994 patients with AL was recruited. The proportions of infected cases (27.78% versus 28.31%, p = 0.888) and the HAI incidence (21.29 versus 22.82 per 1,000 patient-days at risk, p = 0.733) were comparable among AML and ALL patients, respectively. Compared with ALL patients, higher risks of HAIs were found among AML patients with increasing duration of chemotherapy or lower hemoglobin level. Meanwhile, increased length of stays during previous cycles of chemotherapy, lower level of platelets, and diabetes were associated with higher risks of HAIs among ALL patients compared with AML patients. In conclusion, our results found that AML and ALL patients experienced different risks of HAIs associated with diverse relevant factors. Future multi-center studies are needed to provide stronger evidence. 
Introduction
Healthcare-associated infections (HAIs) affect many patients worldwide. They are closely associated with longer hospital stays, increased hospitalization costs, and even higher mortality [1] . According to the European Centers for Disease Prevention and Control (ECDC), approximately 4.1 million patients develop HAI in Europe each year [2] . In China, HAIs have also been shown to be prevalent. One study in China found that the incidence of HAIs was as high as 30.78% among adult patients with acute leukemia (AL) [3] .
Indeed, the huge populations in major Chinese cities have that are able to accommodate more than 4,500 patients. These super hospitals tend to be overcrowded, with their medical staff working under immense pressure. These would impose challenges to effective HAI surveillance and control in these hospitals. In order to overcome these challenges, a better understanding on the causal factors of HAIs is required. AL, a type of severe hematological malignancy, can be classified into two different categories-acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)-based on the lineage of the malignant cells [4] . The
French-American-British (FAB) classification system has divided AML into eight subtypes (M0 through M7), and ALL into three subtypes (L1 through L3), based on the morphology and degree of maturity of the cancer cells [5] .
FAB classification has been widely used around the world eventhough a new classification system was developed by the World Health Organization (WHO) [6] . The rapid development of medical technology has contributed to a significant progress in the development of effective therapeutic treatment of AL, which greatly reduces the overall mortality among AL patients [7, 8] . Nevertheless, these patients are highly vulnerable to the development of HAIs due to underlying diseases such as diabetes, prolonged neutropenia (absolute neutrophil count <1.5×10 9 cells/L), aggressive treatment strategies and medication use [9, 10] , and more importantly, the use of chemotherapy [11, 12] . Intense chemotherapy using cytotoxic drugs may suppress the immune system, leading to myelosuppression and an increased risk of HAI development [13] .
Most previous studies have tested the etiological pathogens, such as types of bacteria and fungus of HAIs, and identified the potential risk factors for certain groups of AL patients such as bone marrow transplant patients with AL, pediatric AL patients, AML patients or ALL patients [14] [15] [16] [17] [18] [19] [20] . Risk factors that they have identified include neutropenia, chemotherapy, catheterization and so on.
Furthermore, a few studies revealed that AML patients are more prone to the development of pneumonia than ALL patients. Huoi et al. [9] found that hospital-acquired pneumonia incidence was 2.4 per 1,000 patient-days higher among AML patients compared to ALL patients. Garcia et al. [21] also found that the 28-day cumulative incidence rate of pneumonia was 14.5% higher among patients with AML than those with ALL. Nevertheless, little are known about the differences in the characteristics and the relevant factors associated with HAIs experienced by AML and ALL patients. Identifying individuals with high HAI risks and discovering the relevant factors associated with HAIs would help facilitate the development of preventative strategies, so as to minimize the occurrence of HAIs among AL patients. The aim of this study is to compare the different HAI characteristics and relevant factors among AML and ALL patients. The primary objective of our study is to make comparisons on the proportions of infected cases, HAI incidence and relevant factors associated with HAIs between AML and ALL patients. The secondary objective is to investigate and compare the common infection types among AML and ALL patients. We hypothesize that patients with AML would be at higher risks of HAIs than those with ALL.
Materials and methods

Design and participants
This study involved secondary data analysis. The original study, aiming at examining relevant factors of HAIs among AL patients, was a hospital surveillance-based study through administrative-monitored electronic databases. In three consecutive years, all adult patients (identified via administrative-monitored electronic databases and who were admitted for over 48 h into the Hematology Department of a comprehensive tertiary hospital affiliated with a medical school) were included in the study. Those with severe major organ dysfunction and serious complications were excluded. AL patients who previously developed chronic leukemia or myelodysplastic syndrome were also excluded. Categories of AL (AML or ALL) were confirmed by cytogenetic tests, analyses of bone marrow morphology, molecular detection of oncogenic protein, and clinical manifestations. For patients who cannot be classified into a particular subtype of ALL during hospitalization, we classified them as uncertainty.
In this study, all 994 participants of the original study were included in the analysis. Using the commonly accepted rule of thumb of sample size for logistic regression (20 subjects per variable), the sample size was sufficient to ensure an acceptable statistical power for logistic regression models with at most 50 variables.
Definition of HAIs
HAIs were recognized primarily through their definition 81 published by the Centers for Disease Control and Prevention [22] . 
Data collection
Data were extracted from a prospectively designed database named Hospital Infection Surveillance System and Hospital Information System by two trained staff members in infection control, using a self-made information extraction form. Data on five different aspects were collected: (1) demographic characteristics; (2) clinical information, i.e., length of stay (LOS), admission and discharge diagnosis, underlying disease and the use of peripherally inserted central catheter (PICC); (3) AL characteristics (types and subtypes of AL, central nervous system leukemia and marrow proliferation analysis); (4) laboratory test results (routine blood tests) and; (5) details of HAIs (infection on admission, the day of infection and infection types). Finally, 16 potential HAI factors (10 were continuous and 6 were categorical variables) were included in the logistic regression analysis, including body mass index (BMI), LOS, infection on admission, blood transfusion, underlying diseases (for e.g., diabetes), chemotherapy (utilization of chemotherapy, duration of chemotherapy, previous cycles of chemotherapy, cycles of chemotherapy during hospital stay and stage of chemotherapy), blood tests (amount of platelets, white blood cells, hemoglobin and neutrophil granulocyte in blood), and marrow proliferation analysis [21, [23] [24] [25] [26] .
Data analysis
Data were analyzed by SPSS version 22.0 (SPSS, Inc., Chicago, Illinois, USA). Mean ± standard deviation (SD), median and quartile interval (QI), or frequencies and constitute proportions were used for summarizing the characteristics of the sample. The proportions of infected cases were expressed as a percentage of the number of patients with HAIs out of the total number of patients within a particular AL types, and the HAI incidence was expressed as the number of HAIs episodes per 1,000 patient-days of a particular AL types. Then, we created a new variable 'AML' to indicate the two types of AL with the score of 1 representing AML while the score of 0 representing ALL. Chi-square test, Mann-Whitney U test or T-test was used for comparison of the variables between the two AL types. In order to identify the independent relevant factors for HAIs by AL types, we included the interaction terms of the 16 potential factors with AML. Accordingly, all the main effects and interaction terms of the 16 potential factors were included in logistic regression analyses using backward stepwise (likelihood ratio) method. Variables were included with p < 0.05 and excluded with p > 0.1. For the final logistic regression model, results were presented as odds ratio (OR) and 95% confidence intervals (95% CI), and p < 0.05 was considered statistically significant.
Ethics statement
The research protocol was approved by the Ethics Committee of the selected hospital. The collected data remain strictly confidential.
Results
The characteristics and general information of AML and ALL patients
Throughout the study, 994 AL patients were determined to meet the eligibility criteria, and were enrolled into the study among the 1,573 patients admitted to the Department of Hematology. The study participants ranged in age from 18 to 84 years old (42.25 ± 16.01) and 565 (56.8%) participants were male. Among the enrolled individuals, 828 (83.30%) were AML patients, and 166 (16.70%) were ALL patients. A flowchart depicting the recruitment process of the study is presented in Figure 1 .
Generally, ALL patients were significantly younger and had a lower BMI. As shown in Table 1 , there were proportionately more male patients in the ALL group compared with the AML group (65.7% versus 55.1%, respectively, p = 0.007). In addition, more ALL patients were in the induction treatment stage of chemotherapy. A larger proportion of ALL patients used stimulating factors, hormone, immuno-modulators and peripherally inserted central catheter (PICC) for cancer treatment. More ALL patients were diagnosed with polar hyperplasia and fewer of them were diagnosed with active proliferation in the marrow proliferation analysis. All the above differences were statistically significant between patients with AML and ALL (p < 0.05). Other categories were comparable between the two groups. Table 2 presents the characteristics of HAIs acquired by different types and subtypes of AL patients in our study. Among the 994 patients, 277 had acquired HAIs, with a total of 306 HAI episodes. The proportion of infected cases was 27.9%, and that of HAI incidence reached 21.52% (95% CI: 21.24%-21.80%). The differences in the proportions of both infected cases (27.78% versus 28.31%, p = 0.888) and HAI incidence (21.29% versus 22.82% patient-days, p = 0.733) were not statistically significant between AML and ALL groups, respectively. Table 3 shows that the most common types of infection among AML and ALL patients were upper respiratory tract infection (as a proportion of all infection types, 43.39% in AML group and 46.81% in ALL group, p > 0.05) and pneumonia (36.36% in AML group and 31.91% in ALL group, p > 0.05), followed by oral infection and gastrointestinal tract infection. The types of infection in this study were not significantly different between AML and ALL patients.
HAIs characteristics in different types of AL patients
Relevant factors associated with the development of HAIs among patients with AML and ALL
Through adjusted logistic regression analysis, Table  4 shows that five factors including LOS, infection on admission, utilization of chemotherapy, duration of chemotherapy and hemoglobin concentration were factors associated with HAIs in both AML and ALL groups. Specifically, the utilization of chemotherapy and prolonged LOS were associated with increased risks of HAIs (OR >1, p < 0.01), while infection on admission, prolonged duration of chemotherapy and higher level of hemoglobin were associated with lower risk of HAIs (OR <1, p < 0.01). For the patients with diabetes, the risks of HAIs were significantly lower among AML patients compared with ALL patients (OR = 0.279; 95% CI: 0.113~0.691; p = 0.006). With regard to other variables, i.e., increased hospitalization day (OR = 0.797; 95% CI: 0.714~0.890; p < 0.001), more chemotherapy cycle undertaken previously (OR = 0.939; 95% CI: 0.895~0.985; p = 0.010) and higher level of platelets (OR = 0.995; 95% CI: 0.990~0.999; p = 0.025), the risks of HAIs were also lower among AML patients. On the other hand, compared with ALL patients, the risks of HAIs were significantly higher among AML 
Discussion
The primary objective of this retrospective study is to compare the proportions of infected cases and HAI incidence, and the relevant factors associated with HAIs between AML and ALL patient groups. Our findings suggest that the proportion of infected cases and HAI incidence were comparable among AML and ALL patients.
In our study, the overall proportion of infected cases was found to be 27.90% and the total HAI incidence was 21.52% patient-days, which were higher than the study on hematological malignancies [23] , hence this indicates the severe condition of HAIs among AL patients. Interestingly, our data appear to show somewhat contradictions to our hypothesis that AML patients would be at higher risk to develop HAIs than ALL patients. This could be explained by a number of factors, including the use of medication and PICC, bone marrow hyperplasia and induction chemotherapy. First, ALL patients in our study took medication more frequently than AML patients, including stimulating factors, hormone and immuno-modulators. This might leave them at higher risk of developing HAIs, as previous studies showed that the use of steroid hormones medication is likely to result in HAIs in ALL patients [27] .
Second, more patients with ALL were inserted with a PICC, which was previously shown to lead to patients' higher susceptibility to bloodstream infection (BSI) [28] . In our study, the proportion of BSI was indeed higher in ALL group than AML group (6.38% versus 2.48%, respectively) though the difference was not significant. Third, more ALL patients were in a condition of polar hyperplasia, in which the bone marrow cells produce a large number of immature blood cells. These conditions suggest poor health status and a weakened immune system, which make patients more susceptible to HAIs. Fourth, more ALL patients undertaking chemotherapy in this study were under the induction chemotherapy stage. Previous studies have demonstrated that neutropenia usually occurs during the first course of induction chemotherapy [24] , and this increases the risks of infections among patients undertaking induction chemotherapy [24, 28, 29] . These factors could contribute to slightly higher proportions of infected cases and HAI incidence among ALL patients observed in this study. As far as HAI types are concerned, upper respiratory tract infection and pneumonia were the top two common types of infection in our study, which was consistent with previous findings. Garcia et al. [21] demonstrated that pneumonia continues to be a major HAI problem, which was associated with significant morbidity, mortality, and health-care resource utilization among AL patients.
As for relevant factors of HAIs, various relevant factors and interaction terms are found to be associated with HAIs. Prolonged LOS is a risk factor for HAIs, and compared with AML patients, patients with ALL are at higher risks. Recently, Ford et al. [1] found that LOS was associated with the gastrointestinal colonization of vancomycinresistant Enterococcus (VRE). Therefore, AL patients are more prone to infections by various pathogens in a hospital environment, owing to their impaired immune function. Our finding that infection on admission could decrease the risks of HAIs is in contrast to a previous study [23] . The reason may lie in the fact that patients with infections on admission were given antibiotic treatment during hospitalization and this could protect them from further HAIs. Furthermore, it is well established that chemotherapy is very likely to weaken the immune system and is associated with more HAIs. As chemotherapeutic drugs can cause damage to the bone marrow, they lead to the interference to the production of sufficient red blood cells, white blood cells, and platelets. However, in terms of prolonged duration of chemotherapy, AML patients have significantly greater risks of HAIs than ALL patients. The reason may be that AML treatment usually causes a more prolonged period of neutropenia and AML itself is a risk factor for pneumonia, even after adjusted for neutropenia [21] . On the other hand, one study showed that the first course of induction chemotherapy is the stage when HAIs are most likely to occur [24] . Subsequently, as patients progress through the chemotherapy regimen, their risks of developing HAIs decrease. A recent study suggested that platelets play a vital role in inflammation and immune response [25] . Considering that severe thrombocytopenia signifies severity of leukemia, a higher platelets level could be linked to decreased incidence of HAIs [21] . In addition, AL patients may also suffer from hemoglobin deficiency, which may be caused by bone marrow failure and side effects of chemotherapy. This condition leads to the development of symptoms associated with anemia (hemoglobin <110 g/L), which would weaken the immune system [30] . Furthermore, the higher HAI risks associated with diabetes could be due to high blood sugar levels and immunosuppression. Indeed, Dare et al. [31] found that hyperglycemia is associated with higher risks of bacterial or fungal infections, thereby providing a link between diabetes, raised blood sugar levels and HAI risks. There is also an evidence of a dosedependent response between mortality and increasing hyperglycemia among AML patients [32] .
There are a few limitations in our study. First, we HAIs. Third, the data were retrospectively collected from hospital information databases and did not include postdischarge follow-up information. Fourth, this study was a single-center study, with all of the recruited patients from a university teaching hospital, thus the generalizability of our findings to other medical settings cannot be assumed.
Conclusion
In conclusion, we demonstrated that the situation of HAIs 
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